Clinical Trials Directory

Trials / Unknown

UnknownNCT04666532

S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues

Staphylococcus Aureus Translocation From Skin and Nose to Periprosthetic Tissues

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Rothman Institute Orthopaedics · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Surgical site infections (SSI) are a significant clinical issue that requires the use of a great amount of resources. In particular, periprosthetic joint infections (PJIs) have potentially catastrophic effects on patients' health-related quality of life, function, healthcare costs, outcomes and medical implications. National surveillance estimates may under-report the true incidence and when considering the large number of total hip (THA) and total knee arthroplasty (TKA) procedures performed each year. Patients who have a high-level of nasal bacteria have been found to have a risk of surgical site infection that is three to six times the risk compared with noncarriers and low-level carriers. The association between a patient's nasal carriage of S. aureus, specifically MRSA, and PJI has been demonstrated in a systematic review and confirmed in recent cohort studies. While this association seems to be well accepted, no mechanistic explanation has been provided for this association.

Conditions

Timeline

Start date
2020-10-22
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2020-12-14
Last updated
2020-12-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04666532. Inclusion in this directory is not an endorsement.

S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues (NCT04666532) · Clinical Trials Directory